[Congressional Record Volume 166, Number 204 (Thursday, December 3, 2020)]
[House]
[Page H6138]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




       OTHER MEDICATIONS TO TREAT COVID-19 SHOULD BE LOOKED INTO

  (Mr. GROTHMAN asked and was given permission to address the House for 
1 minute.)
  Mr. GROTHMAN. Mr. Speaker, this past July, medical research teams at 
Israel's Hebrew University in Jerusalem and New York's Mount Sinai 
Hospital released a study indicating that the FDA-approved cholesterol 
drug fenofibrate may significantly downgrade the severity of COVID-19.
  The medical teams were led by Hebrew University Professor Ya'acov 
Nahmias and Mount Sinai's Dr. Benjamin tenOever. During their research, 
they found the novel coronavirus and studies conducted on human lung 
tissue found that COVID-19 prevents the routine burning of 
carbohydrates, which leads to fat in the lungs, which causes people to 
die.
  What happens is that people take fenofibrate, which is a drug that 
was commonly used for high cholesterol treatment, and it stops this 
inflammation and improves people's respiratory systems.
  Right now, these doctors are not given the support they should be 
given by the CDC and the NIH. We have a lot of people dying of 
coronavirus, and I think our people should not be too proud to 
recognize that sometimes cures are made in other countries.
  I strongly encourage the CDC to look at fenofibrate and these two 
great researchers.

                          ____________________